Company Filing History:
Years Active: 2025
Title: Innovations of Mengying Xia in Biopharmaceuticals
Introduction
Mengying Xia is a notable inventor based in Shanghai, China. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibodies. Her work focuses on enhancing therapeutic options for various diseases through advanced antibody technology.
Latest Patents
Mengying Xia holds a patent for a tetravalent bispecific antibody against PD-1 and PD-L1. This invention provides an antibody that binds to human PD-L1, along with a tetravalent bispecific antibody constructed based on this binding. The unique aspect of this antibody is that it requires no Fc modification and avoids mismatch problems. The preparation method is straightforward, and the biological activities and physical and chemical properties of the tetravalent bispecific antibody are comparable to or even superior to those of traditional monoclonal antibodies.
Career Highlights
Mengying Xia is associated with Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Her role in the company has been pivotal in advancing research and development in the biopharmaceutical sector. She has demonstrated a strong commitment to innovation and excellence in her field.
Collaborations
Mengying Xia has collaborated with notable colleagues, including Zhenping Zhu and Jie Zhao. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mengying Xia's contributions to the field of biopharmaceuticals, particularly through her innovative patent, highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in therapeutic antibody development.